The Washington Post | October 14, 2021
“What is your end point?” asked Lawrence Gostin, who heads Georgetown University’s O’Neill Institute for National and Global Health Law. “Is your end point just the antibody response, which does seem to wane? Is your end point the actual, full immune response with all of the body’s mechanisms to remember the virus and attack it?”